Liontown Selects InEight Document to Support Mining Project Information Management D.A. Davidson Acts as Exclusive Financial Advisor to ActivePipe on Its Sale to MoxiWorks
NEW YORK–(BUSINESS WIRE)–#DADavidsonIB–D.A. Davidson & Co. announced today that it has served as exclusive strategic…
Equalum Unveils Continuous Data Integration Platform 3.0
World’s Most Performant and Scalable Solution Now Supports all Required Cloud Targets – Performing Complex…
TPG RE Finance Trust, Inc. Reports Operating Results for the Fourth Quarter and Full Year Ended December 31, 2021
NEW YORK–(BUSINESS WIRE)–TPG RE Finance Trust, Inc. (NYSE: TRTX) (“TRTX” or the “Company”) reported its…
KBRA Assigns a Preliminary Rating to Gracie Point International Funding 2022-1, Series 2022-1
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns a preliminary rating to one class of notes issued by Gracie…
Nu Holdings Ltd. Reports Fourth Quarter and Full Year 2021 Financial Results
SÃO PAULO–(BUSINESS WIRE)–Nu Holdings Ltd. (NYSE: NU | B3: NUBR33), (“Nu” or the “Company”), one…
Beverly K. Carmichael Joins Viad Corp Board of Directors
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Viad Corp (NYSE:VVI) today announced the appointment of Beverly K. Carmichael as an…
ConocoPhillips Announces Transaction Details for Debt Exchange Offers for up to $3.0 Billion of Debt Securities
HOUSTON–(BUSINESS WIRE)–ConocoPhillips (NYSE: COP) (“COP”) announced today that it is commencing a private offer to…
Elanco Announces the Addition of Rajeev (Bobby) Modi to Lead U.S. Pet Health
GREENFIELD, Ind.–(BUSINESS WIRE)–Elanco Animal Health (NYSE: ELAN) announced today the appointment of Rajeev (Bobby) Modi…
Celldex to Host Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights Conference Call
HAMPTON, N.J., Feb. 22, 2022 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced it…
Arcutis Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Received U.S. Food and Drug Administration (FDA) acceptance of the New Drug Application (NDA) for…
Cara Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
STAMFORD, Conn., Feb. 22, 2022 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage…
Open Eye Consortium Announces the Release of Its 400Gbps and 800Gbps Long Reach and Short Reach Specifications
100 Gbps per lane, long reach, single-mode specification is available to the public today 100…
Tetra Tech Appoints Prashant Gandhi as New Board Member
PASADENA, Calif.–(BUSINESS WIRE)–#esg—Tetra Tech, Inc. (NASDAQ: TTEK), a leading provider of high-end consulting and engineering…
Cybersecurity Leader guardDog.ai Appoints Home Automation Expert Glenn Merlin Johnson to Advisory Board
-New appointment will further advance guardDog.ai’s role in home automation dealer network for integration of…
TechTarget Named to Forbes’ 2022 List of America’s Best Mid-Sized Companies
NEWTON, Mass.–(BUSINESS WIRE)–TechTarget, Inc. (Nasdaq: TTGT), the global leader in B2B technology purchase intent data…
Monnit Founder and CEO Wins 2021 IoT Czar of the Year Award from IoTInnovator.com
IoT Leader Focuses on Helping Businesses Achieve IoT’s Transformative Value SALT LAKE CITY–(BUSINESS WIRE)–#IIoT–IoTInnovator.com presented…
Ventract, LLC – Minority-Owned ‘Tech Startup Is in a Race to Be the First Artificial Intelligent Property Management Procurement Officer’
NORWALK, Conn.–(BUSINESS WIRE)–#HUD—Ventract has been a breath of fresh air in the Property Management Industry,…
KBRA Assigns Preliminary Ratings to GS Mortgage-Backed Securities Trust 2022-NQM1 (GSMBS 2022-NQM1)
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to 27 classes of mortgage pass-through certificates from GS…
Sanofi’s Board of Directors proposes the appointment of Carole Ferrand, Emile Voest and Antoine Yver as independent Directors
Sanofi’s Board of Directors proposes the appointment of Carole Ferrand, Emile Voest and Antoine Yver…
AB Science announces the publication of the masitinib positive pivotal Phase 3 trial in progressive forms of multiple sclerosis in the journal Neurology® Neuroimmunology & Neuroinflammation
PRESS RELEASE PUBLICATION OF THE MASITINIB PIVOTAL PHASE 3 CLINICAL TRIAL IN PROGRESSIVE FORMS…